– ERAPERmed project ”Sparekid”. Multi-markers risk assessment of kidney sensitivity to injury to 

   personalize pervention of acute kidney injury (2023-2026). Eutox partners Ortiz/Schanstra.

– ERAPERmed project ”SIGNAL”, Body fluid proteome SIGnatures for persoNALised intervention

   to pervent cardiovascular and renal complications in diabetes (2023-2026).

    Eutox partners Ortiz/Mischak/Schanstra

– Second funding period “Mechanisms of cardiovascular  complications  on chronic kidney disease”,  

  SFB/TRR 219  (2022-2025); DFG-Project-ID 322900939 (Fliser/Jankowski)

– MI-TRAM (Multi-compatible Implantable Toxin Removal Augmentation Module 

   with fluid sensing) features researchers from IMEC, RWTH Aachen

  University Medical Center, UMC Utrecht, and University

– “treatCKD” Novel compounds for the treatment of chronic kidney disease

   (01/2022-31/2024). Grant ID: ANR-21-CE18-0031 (Argiles, Schanstra)

 – DisCo-1 HORIZON-MSCA-2021 Grand agreement No. 101072828             

– PerstIgAN Funded ERA-Net PerMed programme 2019-2021                     

– UriCoV Funded ERA-Net PerMed programme 2022                               

– Kidnew: Breakthrough technologies for an implantable artificial kidney.  HORIZON-EIC-2022-Pathfinder Open 2022 Programme under grand agreement No. 101099092

–BAKtotheFUTURE: BioArtificial Kidney device consisting of living membranes for improved kidney replacement therapy. NWO-ENW-Open Technology programme, Grand No. 20775

– ERAPERmed  dialysis “Patient-Reported Outcome, Biodata and Process

   Data to Evaluate Dialysis Tolerability”  (October 2020 to 2022)

– EU-ITN “STRATEGY-CKD”  System omics to unravel the                          

  gut-kidney axis in chronic kidney disease (2019-2024)

  European Union’s Horizon 2020, Grant agreement ID:     860329

 (Glorieux, Argiles, Burtey, Jankowski, Masereeuw,  Mischak, Perna,

 Vlahoua)

– ERA-Permed grant “Kidney Attack”, Multidimensional                               

stratification for treatment of acute kidney injury (2019-2022).

Grant agreement   ID: U1048 (Ortiz, Mischak, Schanstra)

– EU-ITN “CaReSyAn  (2018- 2021) CArdioREnal SYndrome  ANalysis                          

European Union’s Horizon 2020, Grant agreement ID: 764474

(Argiles, Jankowski, Mischak, Schanstra, Stenvinkel, Vlahou)

– SFB TRR 219  (2018 – 2021) “Mechanisms of Cardiovascular

Complications in Chronic Kidney Disease”                                                            

 

– FP7- Health   EU-Mascara  (2011-2016)                                                                                 

  (Fliser, Mischak, Jankowski, Wiecek)